vs
CENTERSPACE（CSR）与NATURAL ALTERNATIVES INTERNATIONAL INC（NAII）财务数据对比。点击上方公司名可切换其他公司
CENTERSPACE的季度营收约是NATURAL ALTERNATIVES INTERNATIONAL INC的1.9倍（$65.1M vs $34.8M），NATURAL ALTERNATIVES INTERNATIONAL INC净利率更高（-7.3% vs -23.0%，领先15.7%），NATURAL ALTERNATIVES INTERNATIONAL INC同比增速更快（2.1% vs -3.0%），过去两年NATURAL ALTERNATIVES INTERNATIONAL INC的营收复合增速更高（17.7% vs 0.0%）
Centerspace是一家专注于多户住宅物业持有、运营与开发的房地产投资企业，核心业务覆盖美国中西部及落基山西部区域，面向不同租户群体提供经济型及高端住宅选择，重视租户体验与资产长期价值增长。
天然替代品国际公司（NAI）是一家总部位于美国加利福尼亚州卡尔斯巴德的企业，主打营养补充剂生产，知名产品包括Juice Plus。公司由马克·A·勒杜创立于1980年，生产基地分布在美国加利福尼亚州维斯塔、瑞士与日本，在营养补充剂代工生产领域拥有多年经验。
CSR vs NAII — 直观对比
营收规模更大
CSR
是对方的1.9倍
$34.8M
营收增速更快
NAII
高出5.1%
-3.0%
净利率更高
NAII
高出15.7%
-23.0%
两年增速更快
NAII
近两年复合增速
0.0%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $65.1M | $34.8M |
| 净利润 | $-15.0M | $-2.6M |
| 毛利率 | — | 7.2% |
| 营业利润率 | — | -5.3% |
| 净利率 | -23.0% | -7.3% |
| 营收同比 | -3.0% | 2.1% |
| 净利润同比 | -258.1% | -16.5% |
| 每股收益（稀释后） | $-0.49 | $-0.42 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CSRNAII
| Q1 26 | $65.1M | — | ||
| Q4 25 | $66.6M | $34.8M | ||
| Q3 25 | $71.4M | $37.7M | ||
| Q2 25 | $68.5M | $33.9M | ||
| Q1 25 | $67.1M | $28.8M | ||
| Q4 24 | $66.4M | $34.1M | ||
| Q3 24 | $65.0M | $33.1M | ||
| Q2 24 | $65.0M | $29.5M |
净利润CSRNAII
| Q1 26 | $-15.0M | — | ||
| Q4 25 | $-18.4M | $-2.6M | ||
| Q3 25 | $53.8M | $-291.0K | ||
| Q2 25 | $-14.5M | $-7.2M | ||
| Q1 25 | $-3.7M | $-2.2M | ||
| Q4 24 | $-5.1M | $-2.2M | ||
| Q3 24 | $-1.0M | $-2.0M | ||
| Q2 24 | $-1.3M | $-1.9M |
毛利率CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | 96.5% | 7.2% | ||
| Q3 25 | 96.5% | 11.7% | ||
| Q2 25 | 96.5% | 10.4% | ||
| Q1 25 | 96.4% | 6.3% | ||
| Q4 24 | 96.5% | 4.9% | ||
| Q3 24 | 96.6% | 6.8% | ||
| Q2 24 | 96.6% | 4.8% |
营业利润率CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | -15.9% | -5.3% | ||
| Q3 25 | — | 0.8% | ||
| Q2 25 | -9.9% | -5.7% | ||
| Q1 25 | 7.1% | -7.3% | ||
| Q4 24 | 4.3% | -8.2% | ||
| Q3 24 | 9.8% | -5.5% | ||
| Q2 24 | 11.1% | -8.6% |
净利率CSRNAII
| Q1 26 | -23.0% | — | ||
| Q4 25 | -27.7% | -7.3% | ||
| Q3 25 | 75.3% | -0.8% | ||
| Q2 25 | -21.2% | -21.3% | ||
| Q1 25 | -5.6% | -7.6% | ||
| Q4 24 | -7.6% | -6.4% | ||
| Q3 24 | -1.6% | -6.0% | ||
| Q2 24 | -2.0% | -6.4% |
每股收益（稀释后）CSRNAII
| Q1 26 | $-0.49 | — | ||
| Q4 25 | $-1.08 | $-0.42 | ||
| Q3 25 | $3.19 | $-0.05 | ||
| Q2 25 | $-0.87 | $-1.21 | ||
| Q1 25 | $-0.22 | $-0.37 | ||
| Q4 24 | $-0.31 | $-0.37 | ||
| Q3 24 | $-0.40 | $-0.33 | ||
| Q2 24 | $-0.19 | $-0.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.6M | $3.8M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $695.0M | $67.0M |
| 总资产 | $1.9B | $153.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CSRNAII
| Q1 26 | $7.6M | — | ||
| Q4 25 | $12.8M | $3.8M | ||
| Q3 25 | $12.9M | $7.7M | ||
| Q2 25 | $12.4M | $12.3M | ||
| Q1 25 | $11.9M | $10.6M | ||
| Q4 24 | $12.0M | $8.7M | ||
| Q3 24 | $14.5M | $10.2M | ||
| Q2 24 | $14.3M | $12.0M |
总债务CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | $1.0B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.1B | — | ||
| Q1 25 | $955.5M | — | ||
| Q4 24 | $955.4M | — | ||
| Q3 24 | $921.3M | — | ||
| Q2 24 | $931.7M | — |
股东权益CSRNAII
| Q1 26 | $695.0M | — | ||
| Q4 25 | $719.2M | $67.0M | ||
| Q3 25 | $748.6M | $69.0M | ||
| Q2 25 | $710.1M | $68.4M | ||
| Q1 25 | $636.8M | $76.6M | ||
| Q4 24 | $752.0M | $79.1M | ||
| Q3 24 | $672.5M | $80.2M | ||
| Q2 24 | $680.7M | $82.6M |
总资产CSRNAII
| Q1 26 | $1.9B | — | ||
| Q4 25 | $1.9B | $153.3M | ||
| Q3 25 | $2.1B | $156.9M | ||
| Q2 25 | $2.0B | $151.9M | ||
| Q1 25 | $1.9B | $154.9M | ||
| Q4 24 | $1.9B | $156.1M | ||
| Q3 24 | $1.9B | $161.3M | ||
| Q2 24 | $1.9B | $162.3M |
负债/权益比CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | 1.42× | — | ||
| Q3 25 | 1.53× | — | ||
| Q2 25 | 1.57× | — | ||
| Q1 25 | 1.50× | — | ||
| Q4 24 | 1.27× | — | ||
| Q3 24 | 1.37× | — | ||
| Q2 24 | 1.37× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $-6.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.3M |
| 自由现金流率自由现金流/营收 | — | -20.9% |
| 资本支出强度资本支出/营收 | 0.3% | 2.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-5.2M |
8季度趋势，按日历期对齐
经营现金流CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | $98.5M | $-6.3M | ||
| Q3 25 | $35.1M | $-4.0M | ||
| Q2 25 | $25.3M | $3.3M | ||
| Q1 25 | $25.4M | $6.0M | ||
| Q4 24 | $98.2M | $37.0K | ||
| Q3 24 | $32.3M | $-3.4M | ||
| Q2 24 | $22.9M | $-2.7M |
自由现金流CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | $64.3M | $-7.3M | ||
| Q3 25 | $25.7M | $-5.1M | ||
| Q2 25 | $15.5M | $1.9M | ||
| Q1 25 | $20.4M | $5.2M | ||
| Q4 24 | $41.6M | $-1.0M | ||
| Q3 24 | $20.5M | $-3.7M | ||
| Q2 24 | $9.1M | $-3.8M |
自由现金流率CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | 96.5% | -20.9% | ||
| Q3 25 | 36.0% | -13.4% | ||
| Q2 25 | 22.7% | 5.6% | ||
| Q1 25 | 30.4% | 18.0% | ||
| Q4 24 | 62.6% | -3.0% | ||
| Q3 24 | 31.5% | -11.3% | ||
| Q2 24 | 14.0% | -12.7% |
资本支出强度CSRNAII
| Q1 26 | 0.3% | — | ||
| Q4 25 | 51.3% | 2.7% | ||
| Q3 25 | 13.1% | 2.7% | ||
| Q2 25 | 14.2% | 4.3% | ||
| Q1 25 | 7.5% | 2.8% | ||
| Q4 24 | 85.3% | 3.1% | ||
| Q3 24 | 18.2% | 0.9% | ||
| Q2 24 | 21.2% | 3.5% |
现金转化率CSRNAII
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CSR
暂无分部数据
NAII
| Private Label Contract Manufacturing | $32.8M | 94% |
| Patent And Trademark Licensing | $2.0M | 6% |
